tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MIRM Stock Latest News

FDA approves Mirum treatment for cerebrotendinous xanthomatosis
The FlyFDA approves Mirum treatment for cerebrotendinous xanthomatosis
17h ago
MIRM
Metagenomi appoints Eric Bjerkholt to board of directors
PremiumThe Fly
Metagenomi appoints Eric Bjerkholt to board of directors
1M ago
MGX
MIRM
Mirum Pharmaceuticals sees FY24 revenue $336M, consensus $332.78M
PremiumThe Fly
Mirum Pharmaceuticals sees FY24 revenue $336M, consensus $332.78M
1M ago
MIRM
Mirum Pharmaceuticals sees FY25 revenue $420M-$435M, consensus $418.15M
PremiumThe Fly
Mirum Pharmaceuticals sees FY25 revenue $420M-$435M, consensus $418.15M
1M ago
MIRM
Mirum Pharmaceuticals Surpasses 2024 Sales Guidance
PremiumCompany Announcements
Mirum Pharmaceuticals Surpasses 2024 Sales Guidance
1M ago
8K
MIRM
Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities
PremiumThe FlyMirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities
3M ago
MIRM
Mirum Pharmaceuticals price target raised to $50 from $44 at Baird
Premium
The Fly
Mirum Pharmaceuticals price target raised to $50 from $44 at Baird
3M ago
MIRM
Mirum Pharmaceuticals price target raised to $68 from $65 at Citi
Premium
The Fly
Mirum Pharmaceuticals price target raised to $68 from $65 at Citi
3M ago
MIRM
Mirum Pharmaceuticals Reports Strong Q3 Sales Growth
PremiumCompany Announcements
Mirum Pharmaceuticals Reports Strong Q3 Sales Growth
3M ago
MIRM
Mirum Pharmaceuticals reports Q3 EPS (30c), consensus (45c)
PremiumThe Fly
Mirum Pharmaceuticals reports Q3 EPS (30c), consensus (45c)
3M ago
MIRM
MIRM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MIRM Upcoming Earnings Report: What to Expect?
3M ago
MIRM
Mirum Pharmaceuticals price target raised to $49 from $47 at Leerink
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $49 from $47 at Leerink
4M ago
MIRM
Mirum Pharmaceuticals granted Breakthrough Therapy Designation for volixibat
PremiumThe FlyMirum Pharmaceuticals granted Breakthrough Therapy Designation for volixibat
4M ago
MIRM
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
OGI
ASND
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
ABEO
ADAP
Mirum Pharmaceuticals price target raised to $60 from $50 at Cantor Fitzgerald
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $60 from $50 at Cantor Fitzgerald
7M ago
MIRM
Mirum Pharmaceuticals price target raised to $44 from $39 at Baird
PremiumThe Fly
Mirum Pharmaceuticals price target raised to $44 from $39 at Baird
7M ago
MIRM
Mirum says on track to achieve 2024 sales outlook $310M-$320M
PremiumThe Fly
Mirum says on track to achieve 2024 sales outlook $310M-$320M
7M ago
MIRM
Mirum Pharmaceuticals reports Q2 EPS (52c), consensus (47c)
PremiumThe Fly
Mirum Pharmaceuticals reports Q2 EPS (52c), consensus (47c)
7M ago
MIRM
Mirum Pharmaceuticals announces label expansion for Livmarli
PremiumThe FlyMirum Pharmaceuticals announces label expansion for Livmarli
7M ago
MIRM
Mirum Pharmaceuticals: EU approves LIVMARLI for patients with PFIC
Premium
The Fly
Mirum Pharmaceuticals: EU approves LIVMARLI for patients with PFIC
8M ago
MIRM
Mirum Pharmaceuticals submits new drug application to FDA for chenodiol
Premium
The Fly
Mirum Pharmaceuticals submits new drug application to FDA for chenodiol
8M ago
MIRM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >